ES2602823T3 - Proceso para la preparación de drospirenona - Google Patents

Proceso para la preparación de drospirenona Download PDF

Info

Publication number
ES2602823T3
ES2602823T3 ES09159293.1T ES09159293T ES2602823T3 ES 2602823 T3 ES2602823 T3 ES 2602823T3 ES 09159293 T ES09159293 T ES 09159293T ES 2602823 T3 ES2602823 T3 ES 2602823T3
Authority
ES
Spain
Prior art keywords
drospirenone
preparation
antimineralocorticoid
progestogenic
androstane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09159293.1T
Other languages
English (en)
Inventor
Francesca Costantino
Roberto Lenna
Silvia Piuri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industriale Chimica SRL
Original Assignee
Industriale Chimica SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35840070&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2602823(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Industriale Chimica SRL filed Critical Industriale Chimica SRL
Application granted granted Critical
Publication of ES2602823T3 publication Critical patent/ES2602823T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pens And Brushes (AREA)
  • Macromonomer-Based Addition Polymer (AREA)

Abstract

6ß,7ß;15ß,16ß-dimetilen-3ß,5ß-dihidroxi-17α-pregn-21,17-211α-carbolactol.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10

Claims (1)

  1. imagen1
ES09159293.1T 2004-12-06 2005-11-14 Proceso para la preparación de drospirenona Active ES2602823T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002338A ITMI20042338A1 (it) 2004-12-06 2004-12-06 Processo per la preparazione di drospirenone
ITMI20042338 2004-12-06

Publications (1)

Publication Number Publication Date
ES2602823T3 true ES2602823T3 (es) 2017-02-22

Family

ID=35840070

Family Applications (2)

Application Number Title Priority Date Filing Date
ES09159293.1T Active ES2602823T3 (es) 2004-12-06 2005-11-14 Proceso para la preparación de drospirenona
ES05819134T Active ES2355982T3 (es) 2004-12-06 2005-11-14 Procedimiento para la preparación de drospirenona.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES05819134T Active ES2355982T3 (es) 2004-12-06 2005-11-14 Procedimiento para la preparación de drospirenona.

Country Status (20)

Country Link
US (3) US20080207575A1 (es)
EP (2) EP2108652B1 (es)
JP (1) JP5626616B2 (es)
CN (1) CN101065396B (es)
AT (1) ATE491716T1 (es)
BR (1) BRPI0517752C1 (es)
CA (1) CA2589928C (es)
CL (1) CL2007001581A1 (es)
CY (1) CY1111209T1 (es)
DE (1) DE602005025396D1 (es)
DK (1) DK1828222T3 (es)
ES (2) ES2602823T3 (es)
IL (1) IL183645A (es)
IT (1) ITMI20042338A1 (es)
MX (1) MX2007006701A (es)
PL (1) PL1828222T3 (es)
PT (1) PT1828222E (es)
SI (1) SI1828222T1 (es)
WO (1) WO2006061309A1 (es)
ZA (1) ZA200705492B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008000936A (es) * 2005-07-21 2008-03-27 Bayer Schering Pharma Ag Proceso para producir 3-oxo-pregn-4-eno-21,17-carbolactonas por oxidacion libre de metales de 17-(3-hidroxipropil)-3,17-dihidroxia ndrostanos.
US7319154B2 (en) 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
ES2311927T5 (es) * 2005-07-21 2014-09-08 Bayer Pharma Aktiengesellschaft Proceso para la producción de 3-oxo-pregn-4-en-21,17-carbolactonas por la oxidación sin metales de 17-(3-hidroxipropil)-3,17-dihidroxiandrostanos
MX2008016571A (es) * 2007-05-01 2009-03-09 Sicor Inc Proceso para preparar drospirenona y su intermediarios.
DE102007027635A1 (de) * 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007030596B3 (de) * 2007-06-28 2009-03-12 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Herstellung von 17-(3-Hydroxypropyl)-17-hydroxysteroiden
DE602007011250D1 (de) * 2007-07-26 2011-01-27 Newchem S P A Herstellungsverfahren für Drospirenon
WO2009111574A2 (en) * 2008-03-05 2009-09-11 Evestra, Inc. BISMETHYLENE-17α CARBOLACTONES AND RELATED USES
US8222237B2 (en) * 2008-11-25 2012-07-17 Evestra, Inc. Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
ES2432063T3 (es) * 2009-06-16 2013-11-29 Crystal Pharma, S.A.U. Procedimiento para la obtención de 17-espirolactonas en esteroides
CN101775057B (zh) * 2010-02-09 2014-07-16 浙江仙琚制药股份有限公司 屈螺酮及其中间体的制备方法
CN101830959B (zh) * 2010-05-27 2012-07-18 杭州龙山化工有限公司 一种曲螺酮的合成方法
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP2415778B1 (en) 2010-08-03 2013-05-15 Newchem S.p.A. Methods for the preparation of Drospirenone and intermediates thereof
CN102040650B (zh) * 2010-10-26 2014-03-26 西安科技大学 串联反应构建甾体-6β,7β-亚甲基结构的方法
WO2012107513A1 (en) 2011-02-10 2012-08-16 Crystal Pharma, S.A.U. Process for obtaining drospirenone
ITMI20111383A1 (it) * 2011-07-25 2013-01-26 Ind Chimica Srl Processo per la preparazione di drospirenone
ITMI20120146A1 (it) * 2012-02-03 2013-08-04 Ind Chimica Srl Processo per la preparazione di composti policiclici insaturi dotati di attivita' farmacologica
CA2856324C (en) 2011-11-22 2019-08-13 Industriale Chimica S.R.L. Process for the preparation of drospirenone
EP2597101A1 (en) 2011-11-22 2013-05-29 Industriale Chimica S.R.L. Process for the preparation of drospirenone
CN102887934B (zh) * 2012-09-20 2015-05-27 杭州福斯特药业有限公司 一种屈螺酮的制备方法
ITMI20130183A1 (it) * 2013-02-08 2014-08-09 Ind Chimica Srl Processo per la preparazione di drospirenone.
EP2958929B1 (en) * 2013-02-20 2017-09-13 Industriale Chimica S.R.L. Process for the preparation of drospirenone
DK2984100T3 (en) * 2013-04-12 2017-07-10 Ind Chimica Srl Process for the preparation of drospirenone
WO2014174338A1 (en) * 2013-04-22 2014-10-30 Industriale Chimica S.R.L. Process for preparing an intermediate useful in the production of drospirenone
CN104174341B (zh) * 2013-05-27 2017-09-26 乌鲁木齐益好天成新型节能材料有限公司 一种固相硅凝胶的制备方法
EP3108889A1 (en) 2015-06-23 2016-12-28 Philippe Perrin Drospirenone-based contraceptive for a female patient affected with excess weight
BR112017028048A2 (pt) 2015-06-23 2018-09-04 Laboratorios Leon Farma Sa drospirenona como o único ingrediente contraceptivo para uso
CN105017362A (zh) * 2015-07-22 2015-11-04 浙江圃瑞药业有限公司 将表雄酮氧化为雄烷二酮的清洁生产方法
CN110407905B (zh) * 2019-08-22 2021-09-28 武汉九珑人福药业有限责任公司 一种屈螺酮及其中间体的制备方法
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception
CN114437169B (zh) * 2022-01-25 2023-04-07 台州仙琚药业有限公司 一种屈螺酮关键中间体溴代物的合成方法
WO2023152658A1 (en) 2022-02-10 2023-08-17 Lupin Limited Slow release drospirenone tablet composition
AR128632A1 (es) 2022-03-01 2024-05-29 Chemo Res S L Anticonceptivo oral masticable de drospirenona

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042136A1 (de) * 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
EP0075189B1 (en) * 1981-09-21 1985-08-28 Schering Aktiengesellschaft 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
NZ275951A (en) * 1993-12-17 1997-12-19 Upjohn Co Bisnoraldehyde production from bisnoralcohol
DE19633685C1 (de) * 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
MXPA05001857A (es) * 2002-08-16 2005-06-03 Upjohn Co Intermedios esteroideos de 5-androsten-38-ol y procedimientos para su preparacion.
JP3814284B2 (ja) * 2002-11-06 2006-08-23 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ７−カルボキシ置換ステロイドの製造方法
ITMI20040367A1 (it) * 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
HUP0402465A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main intermediates of the process
HUP0402466A2 (en) * 2004-11-30 2006-07-28 Richter Gedeon Vegyeszet Industrial process for preparing 17-hydroxy-6-betha, 7-betha, 15-betha, 16-betha-bis-methylene-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid gamma lacton and the main, intermediates of the process
US7319154B2 (en) * 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes

Also Published As

Publication number Publication date
US8227596B2 (en) 2012-07-24
CA2589928A1 (en) 2006-06-15
ZA200705492B (en) 2008-08-27
SI1828222T1 (sl) 2011-03-31
IL183645A (en) 2012-02-29
CN101065396B (zh) 2012-05-23
JP2008522962A (ja) 2008-07-03
EP1828222B1 (en) 2010-12-15
US20100331291A1 (en) 2010-12-30
ES2355982T3 (es) 2011-04-01
EP2108652A2 (en) 2009-10-14
CY1111209T1 (el) 2015-06-11
IL183645A0 (en) 2007-09-20
CN101065396A (zh) 2007-10-31
ATE491716T1 (de) 2011-01-15
PL1828222T3 (pl) 2011-04-29
US20120264723A1 (en) 2012-10-18
BRPI0517752A (pt) 2008-10-21
ITMI20042338A1 (it) 2005-03-06
PT1828222E (pt) 2011-01-31
JP5626616B2 (ja) 2014-11-19
WO2006061309A1 (en) 2006-06-15
DK1828222T3 (da) 2011-02-21
US20080207575A1 (en) 2008-08-28
EP1828222B9 (en) 2011-08-31
CA2589928C (en) 2013-07-02
DE602005025396D1 (de) 2011-01-27
EP1828222A1 (en) 2007-09-05
BRPI0517752C1 (pt) 2021-05-25
MX2007006701A (es) 2007-11-09
EP2108652A3 (en) 2011-06-22
EP2108652B1 (en) 2016-08-17
BRPI0517752B8 (pt) 2019-02-19
BRPI0517752B1 (pt) 2018-12-26
CL2007001581A1 (es) 2008-01-04

Similar Documents

Publication Publication Date Title
ES2602823T3 (es) Proceso para la preparación de drospirenona
DE602005024470D1 (de) Verfahren zur Herstellung von Drospirenon
BRPI0512993A (pt) uso de um antagonista de pr, kit farmaceuticamente últil, e, método de contracepção em uma fêmea em idade de parto
PE20080273A1 (es) Composicion farmaceutica que contiene un progestageno, un estrogeno y un acido tetrahidrofolico
EP1632237A3 (en) Compositions comprising drospirenone and a complex between ethinyl-estradiol and a cyclodextrin
RS54398B1 (en) THE USE OF FLIBANSERINE FOR THE TREATMENT OF SEXUAL DESIRE DISORDERS IN POSTMENOPAUSE
ATE429416T1 (de) Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
ATE337311T1 (de) Heterocyclylalkylpiperidinderivate, deren herstellung und zusammensetzungen, die diese derivate enthalten
BRPI0214716B8 (pt) kit, preparos, e uso de estrogênio e progestina na fabricação de um medicamento para uso na prevenção de gravidez
JP2005529737A5 (es)
CL2004001317A1 (es) Composicion farmaceutica que comprende el antagonista de receptores de progesterona 11b-(4-acetilfenil)-17b-hidroxi-17 alfa-(1,1,2,2,2-pentafluoroetil)-estra-4,9-dien-3-ona y un antiestrogeno puro; y su uso para tratar una enfermedad dependiente de h
DK1652526T3 (da) Anvendelse af (11beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-on i behandling af svær depressionslidelse
BR9906862A (pt) Uso de uma quantidade eficaz de um agente desubstituição hormonal para o tratamento demenopausa humana e de endometriose
AR049195A1 (es) Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento
EA200701389A1 (ru) Твёрдая пероральная лекарственная форма для контрацепции
BR9814136A (pt) Conjunto contraceptivo, processos de fabricação do mesmo e de tratamento de sangramento, usos de anti-progestogênio, de progestogênio e de anti-progestogênio, e, de um composto.
BR0116127A (pt) Composto, composição farmacêutica, uso de um composto, e, conjunto para a contracepção masculina
RU2002130065A (ru) Состав, обладающий контрацептивной активностью
PE20020709A1 (es) Composiciones de complejos de estrogeno-ciclodextrina
BR0113357A (pt) Composição oral
AR061251A1 (es) Proceso para la preparacion de drospirenona y una composicion farmaceutrica
EP2305267A3 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
WO2007042111A3 (de) Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysf unktionellen uterinen blutung in einheit mit einer oralen kontrazeption
TH54472A (th) องค์ประกอบสำหรับการทำเฝือกปูนพลาสเตอร์ชนิดม้วนและเฝือกปูนพลาสเตอร์ชนิดม้วนที่ได้จากองค์ประกอบนี้